Literature DB >> 10521654

Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function.

A R Muotri1, L da Veiga Pereira, L dos Reis Vasques, C F Menck.   

Abstract

Ribozymes are RNA molecules that possess the dual properties of RNA sequence-specific recognition and site-specific cleavage of other RNA molecules. These properties provide powerful tools for studies requiring gene inhibition, when the DNA sequence is known. The use of these molecules goes beyond basic research, with a potential impact in therapeutical practice in medicine in the near future. In this review, we briefly describe the progress towards developing this class of molecules and its applications for the control of gene expression.

Mesh:

Substances:

Year:  1999        PMID: 10521654     DOI: 10.1016/s0378-1119(99)00334-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Anti-HBV hairpin ribozyme-mediated cleavage of target RNA in vitro.

Authors:  Yu-Hu Song; Ju-Sheng Lin; Nan-Zhi Liu; Xin-Juan Kong; Na Xie; Nan-Xia Wang; You-Xin Jin; Kuo-Huan Liang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

3.  C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification.

Authors:  M Krüger; C Beger; P J Welch; J R Barber; F Wong-Staal
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

4.  Substrate specificity and reaction kinetics of an X-motif ribozyme.

Authors:  Denis Lazarev; Izabela Puskarz; Ronald R Breaker
Journal:  RNA       Date:  2003-06       Impact factor: 4.942

5.  Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.

Authors:  M Krüger; C Beger; P J Welch; J R Barber; M P Manns; F Wong-Staal
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 6.  Genetic targeting of the renin-angiotensin system for long-term control of hypertension.

Authors:  Beverly L Metcalfe; Mohan Raizada; Michael J Katovich
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

7.  Preparation and identification of anti-transforming growth factor beta1 U1 small nuclear RNA chimeric ribozyme in vitro.

Authors:  Ju-Sheng Lin; Yu-Hu Song; Xin-Juan Kong; Bin Li; Nan-Zhi Liu; Xiao-Li Wu; You-Xin Jin
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.